Biopharma and Health Related News

Inovio Develops Novel H3N2 Influenza DNA Vaccine That Generates Cross-Reactive Responses and Provides Complete Protection Against Lethal Preclinical Challenges

H3N2 virus has been one of the most deadly flu strains in the past 50 years; And is always matched with the least effective seasonal influenza vaccine Preclinical work is supported by an NIH grant PLYMOUTH MEETING, Pa., Sept. 17, [...]

PvP Biologics Announces First-in-Human Clinical Trials for a Novel Therapeutic for Celiac Disease

SAN DIEGO and SEATTLE, September 6, 2018 – PvP Biologics, Inc. (“PvP”) today announced the initiation of two first-in-human clinical trials for Kuma062, a product candidate for the treatment of celiac disease. Kuma062 is a uniquely engineered, recombinant enzyme that [...]

Precision BioSciences Announces Collaboration with University of Pennsylvania to Develop Genome Editing Therapeutics

DURHAM, North Carolina, USA, September 04, 2018 – Precision BioSciences today announced an expansion of their ongoing collaboration with the Gene Therapy Program in the Perelman School of Medicine at the University of Pennsylvania (Penn) to pursue research and development [...]

Cronos Group and Ginkgo Bioworks Announce a Landmark Partnership to Produce Cultured Cannabinoids

Leading Companies from Emerging Industries Join Forces to Efficiently Produce High-Purity Cannabinoids at Scale BOSTON and TORONTO, Sept. 4, 2018 /PRNewswire/ - Today, Cronos Group Inc. (NASDAQ : CRON ) (TSX: CRON) ("Cronos Group"), a geographically diversified and vertically integrated cannabis [...]

Teewinot Life Sciences Corporation Announced Today Grant of a U.S. Patent with Claims to Cannabinoid Formulations

Furthers Mission to Address Unmet Therapeutic and Wellness Needs Across the Globe TAMPA, Fla., Aug. 28, 2018 /PRNewswire/ -- Teewinot Life Sciences Corporation, a global leader in the production of cannabinoids for use in the pharmaceutical and nutraceutical markets, and its [...]

bluebird bio and Gritstone Oncology Announce Strategic Collaboration to Develop Novel Cancer Cell Therapies

AMBRIDGE, Mass. & EMERYVILLE, Calif.--(BUSINESS WIRE)--Aug. 23, 2018-- bluebird bio, Inc. (Nasdaq: BLUE) and Gritstone Oncology, Inc. today announced a collaboration to research, develop and commercialize products for the treatment of cancer using cell therapy. Gritstone Oncology will leverage its [...]